
Investors
Accelerating the development of new therapies and improving the diagnosis and treatment of serious diseases, we deliver value for our investors and partners, as well as those whose lives we touch.
We Deliver at a Global Scale
Benefits for all stakeholders
The combination of Median’s ground-breaking technology and world-class expertise perfectly positions us to revolutionize the field of medical imaging, transforming data generation, management, and access all around the world. Benefiting patients, health professionals, our partners and investors.
Press Releases and Corporate Updates

Latest Press Release
Median Technologies announces the availability of the preparatory documents for the Shareholders’ Ordinary General Meeting on October 10, 2023

Latest Corporate Update
Corporate Update – September, 2023
Analyst Coverage
Median Technologies is followed by the analysts listed below.
Any opinions, estimates, forecasts and recommendations regarding Median Technologies made by these analysts are their own. These opinions, estimates, forecasts and recommendations may or may not represent those of Median’s management.
Company
Analyst
Gilbert Dupont
Pierre Alexandre Desir
TP ICAP / Midcap
Claire Deray
Bryan, Garnier & Co
Alex Cogut
Portzamparc
Clément Bassat
Financial Agenda
Next financial communication: annual results 2022 on April 20, 2023 after trading.
Regulatory Documents

Latest Financial report
04/20/2023Annual Financial Report 2022
Download here

Next Shareholder meeting
10/10/2023Shareholders’ Ordinary General Meeting

Other regulated information
Disclosure of Total Number of Voting Rights and Number of Shares in the Capital
Investor Contacts
Median Technologies
Fredrik Braginvestor@mediantechnologies.com
Actifin
Communication financière
Ghislaine Gasparettoggasparetto@actifin.frTel: +33 1 56 88 11 11
TP ICAP MIDCAP
Listing Sponsor
Alice Ayméaayme@midcapp.com